BG Medicine, Inc. (BGMD) Stock News, Earnings & History

(NASDAQ:BGMD)

Enjoy Interactive Tools and Indicators

52wk high: 7.10
52wk low: 1.00
EPS: -1.00
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 38.61M
Avg Vol (3m): 185,862

Latest Headlines

More Articles About BGMD →

Company On Twitter

Company Profile

BG Medicine, Inc. develops and markets diagnostic tests. The Company develops biomarkers that predict a patient's response to a drug therapy, determine the potential toxicity of therapeutic agents to patients, identify patients who have or are likely to develop a specific disease, predict a patient's prognosis once a disease has been diagnosed, and monitor a patient's disease progression.


Insider Trading Cheat Sheet

No insider trading data available for BG Medicine, Inc..

Yahoo, HV, Market Watch, The Wall St. Journal